文献速递白血病

circ-KEL在急性髓系白血病中的表达及其对白血病细胞的调控机制

[Expression of circ-KEL in acute myeloid leukemia and its regulatory mechanisms in leukemic cells].
PubMed 文献 · Zhonghua Xue Ye Xue Za Zhi · 2021-01-01

该研究检测了116例AML患者和40名健康供者骨髓单个核细胞中circ-KEL的表达,发现AML患者circ-KEL显著高表达且高表达者总生存期更短,化疗后其水平下降。机制上circ-KEL通过海绵吸附miR-335-5p调控LRG1,促进白血病细胞增殖并抑制凋亡。

要点

  • AML患者circ-KEL表达较健康对照显著升高,高表达者总生存期更短。
  • 化疗后AML患者circ-KEL表达水平较初诊时下降。
  • circ-KEL通过miR-335-5p/LRG1轴促进白血病细胞增殖并抑制凋亡。

核心结论

  • circ-KEL在AML患者中高表达,与不良预后相关,并通过miR-335-5p/LRG1轴参与AML疾病进展。

研究设计与样本

  • 收集116例AML患者和40名健康者骨髓标本,分离骨髓单个核细胞,用实时定量RT-PCR检测circ-KEL表达。
  • 通过生物信息学分析和双荧光素酶报告基因实验验证circ-KEL与miR-335-5p/LRG1的靶向关系。
  • 运用CCK-8和流式细胞术检测circ-KEL在AML细胞中的生物学作用。

主要发现

  • circ-KEL在AML患者中的相对表达水平(-Δct)为-7.117±1.831,健康对照为-8.669±1.771,P<0.001。
  • circ-KEL高表达患者总生存期明显短于低表达者,P=0.037。
  • AML患者接受化疗后circ-KEL表达水平较初诊时下降。
  • LRG1在AML患者中表达水平较健康人群显著升高,可促进AML细胞增殖并抑制凋亡。
  • 数据库分析显示miR-335-5p高表达患者预后好,且与LRG1水平呈负相关。

临床怎么用

  • circ-KEL高表达与AML患者不良预后相关,或可作为预后评估的潜在分子标志物。
  • circ-KEL/miR-335-5p/LRG1轴为AML发病机制研究提供了潜在靶点方向。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Objective: To explore the expression of circ-KEL in patients with acute myeloid leukemia (AML) and the effect and mechanism of circ-KEL on leukemic cells. Methods: The expression of circ-KEL was detected by quantitative real-time polymerase chain reaction in bone marrow mononuclear cells collected from 116 patients with AML and 40 healthy donors. The correlation of circ-KEL expression with the clinical characteristics of patients with AML was further systematically analyzed. The modulations among circ-KEL, miR-335-5p, and LRG1 were predicted through bioinformatics analysis and validated by dual luciferase assay. Cell proliferation and apoptosis were detected using CCK8 and flow cytometry. Results: The expression of circ-KEL was significantly elevated in patients with AML compared with the healthy controls (Relative expression level, -Δct, AML: -7.117±1.831; control: -8.669±1.771, P<0.001) . Moreover, patients with high circ-KEL expression have significantly worse overall survival. The level of circ-KEL in patients with AML was downregulated after chemo-treatment. In addition, circ-KEL could serve as the sponge of miR-335-5p and regulate LRG1. Bioinformatics analysis showed that miR-335-5p correlates with good prognosis and was negatively associated with LRG1. LRG1 could promote cell proliferation and inhibit cell apoptosis. Our results also exhibited the higher expression of LRG1 in patients with AML. Moreover, circ-KEL exerted functional effects via sponging miR-335-5p and regulating LRG1. Conclusion: circ-KEL expresses highly in patients with AML and correlates with poor prognosis, suggesting its important role in the genesis and progress of AML. 目的: 探讨circ-KEL在急性髓系白血病(AML)患者中的表达及其对AML细胞的调控作用和机制。 方法: 收集116例AML患者以及40名健康者骨髓标本,分离骨髓单个核细胞,使用实时定量RT-PCR法检测circ-KEL的表达水平并分析其与AML患者临床特征之间的关系。通过生物信息学分析以及双荧光素酶报告基因实验等验证circ-KEL与miR-335-5p/LRG1的靶向关系。运用CCK-8、流式细胞术等方法检测circ-KEL在AML细胞中的生物学作用。 结果: circ-KEL在AML患者中的表达较正常人群明显增高(-7.117±1.831对-8.669±1.771,P<0.001),circ-KEL高表达患者总生存期(OS)明显短于低表达者(P=0.037)。AML患者接受化疗后circ-KEL表达水平较初诊时下降。同时,circ-KEL可充当miR-335-5p的"海绵",靶向调节LRG1。数据库分析显示miR-335-5p高表达患者预后好,且其与LRG1水平呈负相关。LRG1可促进AML细胞的增殖,抑制其凋亡,在AML患者中表达水平较健康人群也显著升高。circ-KEL可以通过miR-335-5p/LRG1轴发挥对白血病细胞的促增殖以及抑制凋亡作用。 结论: circ-KEL在AML患者中高表达,与AML患者预后高度相关,通过影响miR-335-5p/LRG1在AML疾病进展中发挥重要作用。.

来源:Zhonghua Xue Ye Xue Za Zhi,查看原文。版权归原作者所有。

引用

  1. Wu ZJ, Sun Q, Gu DL, et al. [Expression of circ-KEL in acute myeloid leukemia and its regulatory mechanisms in leukemic cells]. Zhonghua Xue Ye Xue Za Zhi. 2021. PMID: 33910309. doi:10.3760/cma.j.issn.0253-2727.2021.03.009

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。